TNF-α inhibitory effect of Euphorbia hirta in rats

Pharmaceutical Biology

Volumn 51, Issue 4, 2013, Pages 411-417

  Ahmad, Sheikh Fayaz ^a   Bani, Sarang ^b   Sultan, Phalisteen ^b   Ali, Sheikh Abid ^b   Bakheet, Saleh A ^a   Attia, Sabry M ^a   Abd Allah, Adel R A ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b Indian Institute of Integrative Medicine Formerly Known As Regional Research Laboratory (CSIR)   (India)

Author keywords

Ethanol extract; Flow cytometry; Lipopolysaccharide; Neutrophils

Indexed keywords

ALCOHOL; ANTIINFLAMMATORY AGENT; EUPHORBIA HIRTA EXTRACT; LIPOPOLYSACCHARIDE; PLANT EXTRACT; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ETHNOPHARMACOLOGY; EUPHORBIA HIRTA; EXPERIMENTAL RAT; FEMALE; INHIBITION KINETICS; NEUTROPHIL COUNT; NONHUMAN; PLANT LEAF; RAT; SYNOVIAL FLUID LEVEL;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS; ARTHRITIS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOL; EUPHORBIA; FEMALE; JOINTS; LIPOPOLYSACCHARIDES; NEUTROPHILS; PLANT EXTRACTS; PLANT LEAVES; PLANTS, MEDICINAL; PREDNISOLONE; RATS; RATS, WISTAR; SOLVENTS; SYNOVIAL FLUID; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84875155949     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2012.734315     Document Type: Article

References (39)

1. Anthony DD, Haqqi TM. (1999). Collagen-induced arthritis in mice: An animal model to study the pathogenesis of rheumatoid arthritis. Clin Exp Rheumatol, 17, 240-244.
2. Amin AR. (1999). Regulation of tumor necrosis factor-alpha and tumor necrosis factor converting enzyme in human osteoarthritis. Osteoarthr Cartil, 7, 392-394.
3. Alamanos Y, Drosos AA. (2005). Epidemiology of adult rheumatoid arthritis. Autoimmun Rev, 4, 130-136.
4. Anononymous. (2005). The use of Euphorbia hirta in the treatment of sores, boils and wounds. Personal communication with the chairman, Imo state Traditional Medicine Practioners: Owerri Nigeri.
5. Ackermann C, Kavanaugh A. (2007). Tumor necrosis factor as a therapeutic target of rheumatologic disease. Expert Opin Ter Targets, 11, 1369-1384.
6. Alstergren P, Kopp S. (2006). Insufcient endogenous control of tumor necrosis factor-alpha contributes to temporomandibular joint pain and tissue destruction in rheumatoid arthritis. J Rheumatol, 33, 1734-1739.
7. Amital H, Gilburd B, Shoenfeld Y. (2007). Probiotic supplementation with Lactobacillus casei (Actimel) induces a T1 response in an animal model of antiphospholipid syndrome. Ann N Y Acad Sci, 1110, 661-669.
8. Brennan FM, Maini RN, Feldmann M. (1998). Role of pro-infammatory cytokines in rheumatoid arthritis. Springer Semin Immunopathol, 20, 133-147.
9. Khan B, Ahmad SF, Bani S, Kaul A, Suri KA, Satti NK, Athar M, Qazi GN. (2006). Augmentation and proliferation of T lymphocytes and T-1 cytokines by Withania somnifera in stressed mice. Int Immunopharmacol, 6, 1394-1403.
10. Choy EH, Isenberg DA, Garrood T, Farrow S, Ioannou Y, Bird H, Cheung N, Williams B, Hazleman B, Price R, Yoshizaki K, Nishimoto N, Kishimoto T, Panayi GS. (2002). Terapeutic beneft of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: A randomized, double-blind, placebo-controlled, dose-escalation trial. Arthritis Rheum, 46, 3143-3150.
11. de Vries N, Tak PP. (2005). The response to anti-TNF-alpha treatment: Gene regulation at the bedside. Rheumatology (Oxford), 44, 705-707.
12. Edwards SW. (1994). Biochemistry and Physiology of the Neutrophil. Cambridge University Press: London, p 299.
13. Eldahshan OA. (2011). Isolation and structure elucidation of phenolic compounds of Carob leaves grown in Egypt. Curr Res J Biol Sci, 3, 52-55.
14. Feldmann M, Brennan FM, Maini RN. (1996). Role of cytokines in rheumatoid arthritis. Annu Rev Immunol, 14, 397-440.
15. Georganas C, Liu H, Perlman H, Hofmann A, Timmapaya B, Pope RM. (2000). Regulation of IL-6 and IL-8 expression in rheumatoid arthritis synovial fbroblasts: The dominant role for NF-kappa B but not C/EBP beta or c-Jun. J Immunol, 165, 7199-7206.
16. Hyrich KL, Watson KD, Silman AJ, Symmons DP; British Society for Rheumatology Biologics Register. (2006). Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register. Rheumatology (Oxford), 45, 1558-1565.
17. Ivashkiv LB. (1996). Cytokine expression and cell activation in infammatory arthritis. Adv Immunol, 63, 337-376.
18. Igoli JO, TA Ogaji, Anyiin Tor, Igoli NP. (2005). Traditional medicine practice amongst the Igede people of Nigeria. Part II. Afri J Tra Comp Alt Med, 2, 134-152.
19. Kokwaro JO. (1993). Medicinal Plants in East Africa. 2nd edn. East African Literature Bureau: Nairobi, Kenya.
20. Lind EM, Tallantire AC. (1971). Some Common Flowering Plants of Uganda. Oxford University Press: Nairobi, p 182.
21. Lanhers MC, Fleurentin J, Dorfman P, Mortier F, Pelt JM. (1991). Analgesic, antipyretic and anti-infammatory properties of Euphorbia hirta. Planta Med, 57, 225-231.
22. Lee KH, Chen YS, Judson J P, Chakravarthi S, Sim YM, Er HM. (2008). The efect of water extracts of Euphorbia hirta on cartilage degeneration in arthritic rats. Malays J Pathol, 30, 95-102.
23. Leandro MJ. (2009). Anti-tumour necrosis factor therapy and B cells in rheumatoid arthritis. Arthritis Res Ter, 11, 128.
24. Mohr W, Westerhellweg H, Wessinghage D. (1981). Polymorphonuclear granulocytes in rheumatic tissue destruction. III. an electron microscopic study of PMNs at the pannus-cartilage junction in rheumatoid arthritis. Ann Rheum Dis, 40, 396-399.
25. Matsuno H, Yudoh K, Katayama R, Nakazawa F, Uzuki M, Sawai T, Yonezawa T, Saeki Y, Panayi GS, Pitzalis C, Kimura T. (2002). The role of TNF-alpha in the pathogenesis of infammation and joint destruction in rheumatoid arthritis (RA): A study using a human RA/SCID mouse chimera. Rheumatology (Oxford), 41, 329-337.
26. Marston B, Palanichamy A, Anolik JH. (2010). B cells in the pathogenesis and treatment of rheumatoid arthritis. Curr Opin Rheumatol, 22, 307-315.
27. Nordahl S, Alstergren P, Kopp S. (2000). Tumor necrosis factor-alpha in synovial fuid and plasma from patients with chronic connective tissue disease and its relation to temporomandibular joint pain. J Oral Maxillofac Surg, 58, 525-530.
28. Nakahara H, Nishimoto N. (2006). Anti-interleukin-6 receptor antibody therapy in rheumatic diseases. Endocr Metab Immune Disord Drug Targets, 6, 373-381.
29. OECD (1996). (Organization for Economic Cooperation and Development). Guidelines for testing of Chemicals. Guideline 423, Acute Oral Toxicity-Acute Toxic Class Method, Adopted, March 22.
30. Romero C, Anchez S, Robinson WH, Tomooka BH. (2008). Identifcation of acute phase reactants and cytokines useful for monitoring infiximab therapy in ankylosing spondylitis. Clin Rheumatol, 27, 1429-1435.
31. Soforowa EA. (1982). Medicinal Plant and Traditional Medicine in Africa. John Wiley and Sons: Chichester, p 198.
32. Singh HN, Blancuzzi V, Greenwood S, Skiles JW, O'Byrne EM. (1997). Synovial fuid levels of tumor necrosis factor-alpha in the infamed rat knee: Modulation by dexamethasone and inhibitors of matrix metalloproteinase and phosphodiesterase. Infamm Res, 46 Suppl 2, S153-S154.
33. Singh GD, Kaiser P, Youssouf MS, Singh S, Khajuria A, Koul A, Bani S, Kapahi BK, Satti NK, Suri KA, Johri RK. (2006). Inhibition of early and late phase allergic reactions by Euphorbia hirta L. Phytother Res, 20, 316-321.
34. Shih MF, Cheng YD, Shen CR, Cherng JY. (2010). A molecular pharmacology study into the anti-infammatory actions of Euphorbia hirta L. on the LPS-induced RAW 264.7 cells through selective iNOS protein inhibition. J Nat Med, 64, 330-335.
35. WHO. (1998). Quality Control Guidelines for Medicinal Plant Materials. World Health Organization: Geneva, p 111.
36. Wong Ting Fook, WTH. (1980). The Medicinal Plants of Mauritius. ENDA Publication No. 10, Dakar.
37. Wendling D, Racadot E, Wijdenes J. (1993). Treatment of severe rheumatoid arthritis by anti-interleukin 6 monoclonal antibody. J Rheumatol, 20, 259-262.
38. Watkins LR, Wiertelak EP, Goehler LE, Smith KP, Martin D, Maier SF. (1994). Characterization of cytokine-induced hyperalgesia. Brain Res, 654, 15-26.
39. Wong PK, Campbell IK, Egan PJ, Ernst M, Wicks IP. (2003). The role of the interleukin-6 family of cytokines in infammatory arthritis and bone turnover. Arthritis Rheum, 48, 1177-1189.